Cybin Inc. Secures Additional U.S. Patent

Ticker: HELP · Form: 6-K · Filed: May 8, 2025 · CIK: 1833141

Cybin INC. 6-K Filing Summary
FieldDetail
CompanyCybin INC. (HELP)
Form Type6-K
Filed DateMay 8, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: patent, pharmaceuticals, filing

TL;DR

Cybin Inc. got another US patent, good for their drug pipeline.

AI Summary

Cybin Inc. filed a Form 6-K on May 8, 2025, reporting a news release dated May 8, 2025, regarding an additional U.S. patent. The company, headquartered in Toronto, Ontario, is involved in pharmaceutical preparations.

Why It Matters

Securing additional patents is crucial for pharmaceutical companies as it protects intellectual property and can provide a competitive advantage in the market.

Risk Assessment

Risk Level: low — This filing is a routine report of a news release and does not contain significant financial or operational changes.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K filing is to report a news release issued by Cybin Inc. on May 8, 2025, concerning an additional U.S. patent.

Who signed this report on behalf of Cybin Inc.?

Doug Drysdale, Chief Executive Officer, signed the report on behalf of Cybin Inc.

What is the SIC code for Cybin Inc.?

The Standard Industrial Classification (SIC) code for Cybin Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Where are Cybin Inc.'s principal executive offices located?

Cybin Inc.'s principal executive offices are located at 100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9.

What is the Commission File Number for Cybin Inc.?

The Commission File Number for Cybin Inc. is 001-40673.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on May 8, 2025 by Doug Drysdale regarding CYBIN INC. (HELP).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing